Email Newsletters

Marlborough

Marlborough manufacturer names new president

Web Industries Inc., a Marlborough-based provider of precision converting and outsource manufacturing and 100% employee-owned company, has appointed John Madej as its new president.

Lightpath to run 75 miles of fiber to improve MetroWest connectivity

Lightpath, an all-fiber, infrastructure-based connectivity provider in New York will create a 75-mile expansion of high-count fiber down the I-90 corridor to improve MetroWest internet connectivity.

Nasuni secures $60M, as remote work fuels demand

Nasuni Corp., a Boston cloud storage company with an office in Marlborough, received a $60-million equity investment by new investor Sixth Street Growth in New York.

Marlborough cancer-therapy firm maintains runway through 2023 with $24M in cash

Marlborough drugmaker Phio Pharmaceuticals ended the 2021 fiscal year with $24.1 million cash in hand, enough to carry the drugmaker through the second quarter of 2023.
ADVERTISEMENT

Marlborough industrial property by Raytheon sells for $8M

A nearly 98,000-square-foot industrial complex in Marlborough sold for $8 million in a sale closed Friday, according to the Middlesex South District Registry of Deeds.

Marlborough art auction house acquired by London firm

Skinner, a midsized art auction house with locations in Marlborough and Boston, has been acquired by London-based global auction house Bonhams.

Hologic teams with tennis association to support women’s equality

Marlborough medical device manufacturer Hologic Inc. partnered with the Women’s Tennis Association to further the company’s focus on women’s wellness and equality.

Car wash owner sells Marlborough, Shrewsbury locations for $4.8M

Local entrepreneur Kevin Labadini sold both of his car wash locations to a Canton-based car wash company, with the two sales totaling $4.75 million, according to the registries of deeds.
ADVERTISEMENT

Movers & Shakers for March 7, 2022

Among the hires and promotions in this edition of Movers & Shakers are those at Fletcher Tilton, Open Sky Community Services, AXIOM Learning Solutions, and AAFCPAs.

Phio Pharmaceuticals starts animal tests on potential COVID-19 treatment

Marlborough drugmaker Phio Pharmaceuticals has begun animal studies on an antiviral compound as a potential treatment for SARS-CoV-2 infection, the virus that causes COVID-19.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA